Our objective was to determine the association of serum adiponectin levels with the presence of IFG or DM in Filipinos. This case control study used sera of adult participants in the Philippines' NNHeS: 2003-04. Subjects were divided into: normoglycaemic control, impaired fasting glucose, and type 2 diabetes mellitus. Seventy-seven prediabetic and 83 diabetic subjects were included in the prediabetic and diabetic groups, respectively. There was no significant difference in adiponectin values between control and prediabetic subjects. Diabetic subjects had significantly lower mean serum adiponectin levels (10.7 versus 14.2 µg/ml, p=0.0198) compared with age-and BMI-matched control subjects. Diabetic subjects were found most frequently (43.53%) in the lowest tertile (1.6-7.2 µg/ml) and least frequently (20%) in the highest tertile (14-84 µg/ml) of adiponectin values. We conclude that Filipinos with diabetes mellitus had significantly lower adiponectin levels compared with normoglycaemic subjects.
Introduction
Adiponectin is an important adipocyte hormone, which is believed to be a promising therapeutic target for the management of diabetes and metabolic syndrome. 1, 2 Adiponectin is considered to have anti-inflammatory and antiatherogenic effects. It accumulates in injured endothelium and dose-dependently inhibits the TNF-α signalling in human aortic endothelial cells. 3 It has also been found to reduce the TNF-α production of macrophages through a cyclic AMP-dependent pathway. 4 It appears to impact insulin resistance and the subsequent development of diabetes mellitus. 5, 6 Low adiponectin levels precede and predict type 2 diabetes, 7 while increasing plasma levels of adiponectin correlate with improved insulin sensitivity. 8 Epidemiological studies in African-Americans, Pima Indians, Asian Indians, Japanese-Americans, Japanese and Korean populations support the protective role of adiponectin against diabetes. [9] [10] [11] [12] [13] [14] Similarly, investigations conducted in Filipinos living in San Diego, California, USA suggest that lower levels of adiponectin may explain the ethnic differences in susceptibility to diabetes. [15] [16] [17] tion of adiponectin levels with the presence of diabetes mellitus and IFG.
Methods

Study design
This was a case-control study which used serum samples of adult participants in the NNHeS:2003-04. 18 The NNHeS:2003-04 was the clinical component of the Sixth NNS conducted by FNRI-DOST of the Philippines. It was a collaborative effort of a multi-sectoral task force comprising 14 medical specialty associations, the Department of Health, and the Department of Adult Medicine and Clinical Epidemiology of the University of the Philippines-Philippine General Hospital. Its main objective was to determine the national prevalence of 20 nutrition-related and lifestyle diseases and 14 risk factors among Filipinos 20 years old and above. A total of 4,753 adults from 2,636 randomly selected households covered in the 2003 FIES and Sixth NNS of FNRI-DOST were included. A stratified multistage sampling design was used, covering all regions and provinces except for Batanes. Using the master sample of the FIES of the National Statistics Office, sampling was performed by selecting barangays within a municipality, selecting enumeration areas from these barangays, and selecting households from these enumeration areas. A nationally representative population was generated by sampling 25% of these households. All the members in the sampled household were included in the survey.
The methodology used in the NNHeS:2003-04 was previously published. 18 In the survey, blood samples were drawn by venipuncture after an 8-10-hour fast to determine FPG, serum total cholesterol, HDL-c, LDL-c and triglycerides. The criterion for diabetes was an FPG > 7 mmol/L, a history of diabetes diagnosed by a physician, or an intake of oral hypoglycaemic agents. BP was taken using a conventional mercury sphygmomanometer. Systolic and diastolic pressures were taken from both arms in the morning before blood extraction. Hypertension was defined as a single visit systolic BP of 140 mmHg or more, or a diastolic BP of 90 mmHg or more, or a history of hypertension diagnosed by a physician or nurse.
Inclusion and exclusion criteria
Participants were divided in to: control subjects (baseline FPG < 100, no past personal or family history of diabetes), subjects with IFG (baseline FPG > 100 but < 7 mmol/L and no past history of diabetes), and subjects with type 2 diabetes mellitus (baseline FPG > 7 mmol/L, or previously diagnosed to have type 2 diabetes mellitus by an attending physician). The following exclusion criteria were used: congestive heart failure as defined by the Framingham criteria, established renal disease requiring haemodialysis, angiotensin-converting enzyme inhibitors, angiotensin-II receptor blocking agents, thiazolidinediones and steroids.
Sampling design
Based on the study of Snehalatha et al. 10 on Asian Indians and using http://www.statsdirect.com, a minimum of 78 subjects with IFG and 78 diabetic subjects should be recruited for the study to achieve a power of 80% and a 5% level of significance. In the NNHeS:2003-04 database, there were only 152 (3.2%) and 219 (4.6%) subjects who had IFG and diabetes, respectively. All their records were reviewed consecutively. For each case subject a normoglycaemic control subject matched for age (within 10 years), BMI (within 1 kg/m 2 ), sex and smoking status was selected from the normoglycaemic population of the NNHeS:2003-04. Where more than one control subject fulfilled the criteria, the subject most closely matched with BMI was chosen.
Data collection
Serum adiponectin levels were measured using an ELISA kit (Cat. #EZHADP-61K) (supplied by Linco Research, St Charles, MO, USA), which specifically measures native human adiponectin. Using a 20 µl sample volume, the limit of sensitivity of this assay is 0.78 ng/ml. The assay has a dynamic range of 1.5-100 ng/ml, an intra-assay precision of 1.0-7.4%, inter-assay precision of 2.4-8.4%.
Statistical analysis
Continuous variables were expressed as mean+SD. Categorical variables were expressed in percentages. Unpaired Student's t-test and chi-square analysis were used to compare differences between continuous and categorical variables, respectively. An age-adjusted adiponectin level was obtained using ANCOVA. Serum adiponectin values were divided into tertiles, and the percentage distribution of control, diabetic and prediabetic subjects in each tertile was determined. A significance level of 5% was chosen for all tests (p<0.05). SPSS version 13 was used for statistical analysis.
Ethical considerations
Sera from the adult subjects recruited in the NNHeS:2003-04 were used, as allowed for in the informed consent form signed by the subjects during their initial participation. The research was conducted according to the Declaration of Helsinki. Guidelines for good clinical practice were observed.
Results
Of the 152 subjects with IFG (prediabetes group), 62 were excluded due to medications (4), missing data (14) , lack of an eligible control (8) and insufficient (4) or missing (33) sera. Of the 90 subjects tested for serum adiponectin levels, 12 had adiponectin values below the limit of detection and were likewise excluded. Hence, only 77 (50.7%) prediabetic subjects were included in the final analysis. In the diabetic group, of the 162 subjects identified, 72 were excluded due to medications (18) , insufficient data (10), lack of an eligible control (12) and insufficient (2) or missing (32) sera. Five subjects had adiponectin levels below the limit of detection. Hence, only 83 (51.2%) diabetic subjects made the final analysis, bringing the total sample size to 162 subject pairs. Tables 1 and 2 showed the baseline characteristics of recruited prediabetic and diabetic subjects, respectively. The majority of the subjects were females (61% prediabetics, 60% diabetics) and current non-smokers (67.5% prediabetics, 67.5% diabetics). The mean BMI for both the prediabeticcontrol and diabetic-control groups fell under the overweight category (BMI > 23 kg/m 2 ) by Asia-Pacific classification. Aside from the fasting glucose levels, there was no significant difference between control subjects and subjects with IFG even when adiponectin was stratified by gender (Table 1) . On the other hand, patients with diabetes mellitus had higher total cholesterol (12.5 mmol/L vs. 11.5 mmol/L, p=0.02) and triglyceride levels (10.8 mmol/L vs. 6.6 mmol/L, p<0.05) compared with the control subjects (Table 2) .
There was no significant difference between adiponectin levels of subjects who are normoglycaemic and those with IFG (15.9 µg/ml vs. 14 µg/ml, p=0.4278). In contrast, diabetic subjects had significantly lower mean serum adiponectin levels (10.7 µg/ml vs. 14.2 µg/ml, 95% CI 8.5-13.0 µg/ml, p=0.0198) compared with age-and BMI-matched normoglycaemic control subjects. However, when adiponectin levels were stratified according to gender, only a trend for lower adiponectin levels in male diabetic subjects remained (13.3+1.6 µg/ml in the control group vs. 9.5+1.4 µg/ml in the diabetic group, p=0.054) (see Table 2 ). Women had persistently higher serum adiponectin levels compared with men in all groups, but the differences did not reach statistical significance. Figure 1 shows the distribution of control, prediabetic and diabetic subjects into adiponectin tertiles. There was a direct relationship between serum adiponectin levels and the proportion of control subjects per tertile. Prediabetic subjects had a distribution that was U-shaped, while the distribution of diabetic subjects per tertile had an inverse linear relationship with serum adiponectin levels. Diabetic subjects were found most frequently (43.53%) in the lowest tertile (1.6-7.2 µg/ml) and least frequently (20%) in the highest tertile (14-84 µg/ml) (c 2 =9.694, p=0.008). 
Discussion
This was the first investigation on the association of serum adiponectin levels with hyperglycaemia in Filipinos using a nationwide representative population. Moreover, it was the first investigation on adiponectin levels in Filipino men. In order to control for possible confounding factors, we decided to match our case and control subjects for age, sex, BMI and smoking status. Even when we did not match for the WHR, which had been reported to affect serum adiponectin levels and the progression to diabetes 12 independently of the BMI, no significant differences were noted in the WCs and WHRs of control and case subjects. This gave us greater confidence in the verity of any association noted between hyperglycaemia and serum adiponectin levels in this study.
The only other studies on adiponectin levels in Filipinos were performed in Filipinas living in San Diego, California, USA. In the study involving 163 women, lower adiponectin levels were independently associated with type 2 diabetes after adjusting for age and family history of diabetes. 16 In a cohort of Caucasians, Filipino and African-American women aged 55-80 years screened with 75 g oral glucose tolerance test, Filipinas were noted to have higher plasma glucose levels and diabetes prevalence even in the lowest level of visceral adipose tissue despite the lower body mass index. 17 Adiponectin levels were lower in normoglycaemic Filipinas compared with normoglycaemic Caucasians and African-Americans. Hence, authors theorised that adiponectin levels may explain the difference in ethnic susceptibility to diabetes. 15 Our finding of a significant association between low adiponectin levels and the presence of diabetes mellitus was consistent with data from White Europeans, 7 Pima Indians, 9 Asian Indians, 10 Japanese, [11] [12] Koreans, 13 and African-Americans. 14 The greatest proportion of our diabetic subjects fell under the lowest adiponectin tertile. In our study, the measured adiponectin levels were comparable to those obtained in Asian Indians, 10 Japanese, 12 Japanese-Brazilians, 19 but higher compared with levels obtained in Pima Indians 9 (adiponectin 4.3 (3.6-5.8) µg/ml 21 and Koreans 13 (adiponectin 5+3.7 µg/ml in all diabetic cases, 4.5+3.9 µg/ml in male diabetic cases, 5.9+3.2 µg/ml in female diabetic cases). 13 The difference from Pima Indians was likely attributable to the markedly higher BMI (cases 36.33+6.9 kg/m 2 vs. controls 36.29+6.9 kg/m 2 ). The difference with Koreans was less clear, since aside from the slight differences in BMI (all diabetic patients 25.6+3.5 kg/m 2 , diabetic males 25.1+2.9 kg/m 2 , diabetic females 26.3+4.2 kg/m 2 ), the rest of the demographic variables were similar with our study population. Additional genetic factors could be at play. The lack of any significant difference in mean serum adiponectin levels between control group and subjects with IFG was similar to reports published for the Asian Indians 10 and Japanese women. 12 In Asian Indians this could be partly explained by the similar level of insulin resistance in normoglycaemic and glucose-intolerant subjects. In the Japanese population studied by Daimon et al. 12 despite the higher TNF-α levels and HOMA-IR in subjects with impaired glucose tolerance, the lower serum adiponectin level did not reach statistical significance. No explanation was offered by the authors, but possible confounding factors not clarified in the study were the level of alcohol intake and the menopausal status of the women recruited. In contrast, a study on Japanese-Brazilians 19 noted significantly lower adiponectin levels in glucose-intolerant subjects. However, the glucose-intolerance group comprised subjects with IFG, impaired glucose tolerance or diabetes mellitus. Hence, the association between adiponectin levels and glucose intolerance in the aforementioned study was probably largely attributable to diabetes mellitus.
Female subjects in our study had higher serum adiponectin levels across all groups, but this remained insignificant even when the control and IFG groups were combined for statistical analysis. Such a finding was consistent with two other reports that failed to observe the sex difference. 22, 23 In contrast, women had significantly higher serum adiponectin levels in the study on Asian Indians 10 , while the male sex was strongly associated with a lower adiponectin level in the Funagata study 12 .
Diabetic subjects in this study had higher triglyceride and lower adiponectin levels compared with the control group. This was consistent with the inverse correlation between adiponectin and triglyceride levels noted in the Funagata study. 12 Unfortunately our sample size did not permit a similar correlation analysis. Nevertheless, the inverse relationship noted in previous studies was not surprising considering that hypertriglyceridaemia is associated with insulin resistance.
Since we were working on stored sera, our sample size was limited by the retrievable and usable sera from the NNHeS:2003-04. The final sample size obtained precluded secondary analyses regarding the association of adiponectin levels with other risk factors for atherosclerosis. Another limitation of our study was inherent in the design of the NNHeS:2003-04, which used only the fasting blood sugar and a past diagnosis of diabetes mellitus to detect glucoseintolerant and diabetic subjects. This diagnostic assessment failed to catch subjects with postprandial hyperglycaemia. Whether expanding the prediabetes group to include both IFG and impaired glucose tolerance will change the association with serum adiponectin levels should be the subject of future studies.
Conclusion and recommendations
In summary, we demonstrated that Filipinos with diabetes mellitus had significantly lower adiponectin levels compared with normoglycaemic subjects. Population-based, Filipinospecific investigations on the correlation of adiponectin levels with atherosclerotic risk factors, degree of insulin resistance and subsequent development of the metabolic syndrome and diabetes mellitus are recommended. 
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